BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoefnagel SJM, Mostafavi N, Timmer MR, Lau CT, Meijer SL, Wang KK, Krishnadath KK. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts. PLoS One 2020;15:e0231419. [PMID: 32282835 DOI: 10.1371/journal.pone.0231419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Reference Citation Analysis]
2 Puthenpura MM, Sanaka KO, Qin Y, Thota PN. Management of nondysplastic Barrett’s esophagus: When to survey? When to ablate? Therapeutic Advances in Chronic Disease 2022;13:204062232210867. [DOI: 10.1177/20406223221086760] [Reference Citation Analysis]
3 Iyer PG, Codipilly DC, Chandar AK, Agarwal S, Wang KK, Leggett CL, Rangel Latuche L, Schulte PJ. Prediction of Progression in Barrett's Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00190-2. [PMID: 35217151 DOI: 10.1016/j.cgh.2022.02.033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Paulson TG, Galipeau PC, Oman KM, Sanchez CA, Kuhner MK, Smith LP, Hadi K, Shah M, Arora K, Shelton J, Johnson M, Corvelo A, Maley CC, Yao X, Sanghvi R, Venturini E, Emde AK, Hubert B, Imielinski M, Robine N, Reid BJ, Li X. Somatic whole genome dynamics of precancer in Barrett's esophagus reveals features associated with disease progression. Nat Commun 2022;13:2300. [PMID: 35484108 DOI: 10.1038/s41467-022-29767-7] [Reference Citation Analysis]
5 Cook MB, Thrift AP. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am 2021;31:1-26. [PMID: 33213789 DOI: 10.1016/j.giec.2020.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hoefnagel SJM, Boonstra JJ, Russchen MJAM, Krishnadath KK. Towards Personalized Treatment Strategies for Esophageal Adenocarcinoma; A Review on the Molecular Characterization of Esophageal Adenocarcinoma and Current Research Efforts on Individualized Curative Treatment Regimens. Cancers (Basel) 2021;13:4881. [PMID: 34638363 DOI: 10.3390/cancers13194881] [Reference Citation Analysis]